Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Fuller Laboratories, Inc. — Predicate Candidate Screening
4 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K931557 | FULLER LABORATORIES MYCOPLASM PNEUMONIA IFA-IGG TEST | Fuller Laboratories, Inc. | 1994-03-11 | 346 | 0 |
| K925689 | MERIDIAN EBV-IGG TEST KIT | Fuller Laboratories, Inc. | 1993-10-12 | 334 | 0 |
| K925690 | MERIDIAN EBNA TEST KIT | Fuller Laboratories, Inc. | 1993-10-12 | 334 | 0 |
| K925688 | MERIDIAN EBV-EA TEST KIT | Fuller Laboratories, Inc. | 1993-10-12 | 334 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda